MedTrace Logo

Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia

NCT04699162 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2021-01-14

No results posted yet for this study

Summary

The aim of this study is to describe the survival and relapses of patients with diagnosis of acute lymphoblastic leukemia at two tertiary level hospitals in the metropolitan area of the valley of Mexico

Conditions

Sponsors & Collaborators

  • Christian Omar Ramos-Peñafiel, MD, PhD

    lead OTHER_GOV

Principal Investigators

  • Christian O Ramos-Peñafiel, MD, Ph.D · Hospital General de México Dr. Eduardo Liceaga

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2020-10-31
Completion
2020-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699162 on ClinicalTrials.gov